Zobrazeno 1 - 10
of 209
pro vyhledávání: '"Hans Michael, Kvasnicka"'
Autor:
Theresa E. Schäfer, Lisanne I. Knol, Ferdinand V. Haas, Anna Hartley, Sophie C.S. Pernickel, Attila Jády, Maximiliane S.C. Finkbeiner, Johannes Achberger, Stella Arelaki, Živa Modic, Katrin Schröer, Wenli Zhang, Barbara Schmidt, Philipp Schuster, Sebastian Haferkamp, Johannes Doerner, Florian Gebauer, Maximilian Ackermann, Hans-Michael Kvasnicka, Amit Kulkarni, Selas T.F. Bots, Vera Kemp, Lukas J.A.C. Hawinkels, Anna R. Poetsch, Rob C. Hoeben, Anja Ehrhardt, Antonio Marchini, Guy Ungerechts, Claudia R. Ball, Christine E. Engeland
Publikováno v:
EBioMedicine, Vol 105, Iss , Pp 105219- (2024)
Summary: Background: Pancreatic ductal adenocarcinoma (PDAC) is a tumour entity with unmet medical need. To assess the therapeutic potential of oncolytic virotherapy (OVT) against PDAC, different oncolytic viruses (OVs) are currently investigated in
Externí odkaz:
https://doaj.org/article/06247aac10bb4534989e76e11402c612
Autor:
Daniel Gödde, Stephan Degener, Christine Walles, Rosalie Keller, Nici Markus Dreger, Katharina Graf, Friedrich-Carl von Rundstedt, Hans Michael Kvasnicka, Susanne Krege, Stephan Störkel
Publikováno v:
BMC Urology, Vol 23, Iss 1, Pp 1-6 (2023)
Abstract Background To evaluate the incidence of lymph node degeneration and its association with nodal metastatic pattern in prostate cancer. Methods A retrospective analysis of the submitted lymph node specimen of 390 prostatectomies in 2011 was pe
Externí odkaz:
https://doaj.org/article/abb8f39c38d54ad58c3daf058815b9f9
Autor:
Martin Frejno, Chen Meng, Benjamin Ruprecht, Thomas Oellerich, Sebastian Scheich, Karin Kleigrewe, Enken Drecoll, Patroklos Samaras, Alexander Hogrebe, Dominic Helm, Julia Mergner, Jana Zecha, Stephanie Heinzlmeir, Mathias Wilhelm, Julia Dorn, Hans-Michael Kvasnicka, Hubert Serve, Wilko Weichert, Bernhard Kuster
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Proteome activity has a major role in cancer progression and response to drugs. Here, the authors use comprehensive proteomic and phosphoproteomic data, in conjunction with drug-sensitivity screens, to generate a community resource consisting of land
Externí odkaz:
https://doaj.org/article/edf0d26d1b5949468d163e5ba1741225
Autor:
Hans Michael Kvasnicka, Jürgen Thiele, Carlos E. Bueso-Ramos, William Sun, Jorge Cortes, Hagop M. Kantarjian, Srdan Verstovsek
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-10 (2018)
Abstract Background Myelofibrosis (MF) is a life-shortening complication of myeloproliferative neoplasms associated with ineffective hematopoiesis, splenomegaly, and progressive bone marrow (BM) fibrosis. The oral Janus kinase (JAK) 1/JAK2 inhibitor
Externí odkaz:
https://doaj.org/article/f840a4a89677489b88eb5e6044222747
Autor:
Alfred Zippelius, Michael von Bergwelt-Baildon, Daniel E. Speiser, Stephan Dirnhofer, Giulio Spagnoli, Hans-Michael Kvasnicka, Max Schlaak, Viola A. Heinzelmann-Schwarz, Didier Lardinois, Grzegorz Terszowski, Spasenija Savic, Jens Schreiner, Sebastian Theurich, Kea Martin, Philipp Müller
PDF file - 97K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31695c9c481c2b5589caf74c4d01a02b
https://doi.org/10.1158/2326-6066.22537264.v1
https://doi.org/10.1158/2326-6066.22537264.v1
Autor:
Alfred Zippelius, Michael von Bergwelt-Baildon, Daniel E. Speiser, Stephan Dirnhofer, Giulio Spagnoli, Hans-Michael Kvasnicka, Max Schlaak, Viola A. Heinzelmann-Schwarz, Didier Lardinois, Grzegorz Terszowski, Spasenija Savic, Jens Schreiner, Sebastian Theurich, Kea Martin, Philipp Müller
PDF file - 2651K, Supp. Fig. 1. Dolastatins induce phenotypic DC maturation in vitro. Supp. Fig. 2. Dolastatins induce phenotypic and functional maturation of BM-DCs in vitro. Supp. Fig. 3. Immuno-stimulatory effect of dolastatin 10 is independent of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27fba704c2975dd557cb27ba32be221a
https://doi.org/10.1158/2326-6066.22537267.v1
https://doi.org/10.1158/2326-6066.22537267.v1
Autor:
Alfred Zippelius, Michael von Bergwelt-Baildon, Daniel E. Speiser, Stephan Dirnhofer, Giulio Spagnoli, Hans-Michael Kvasnicka, Max Schlaak, Viola A. Heinzelmann-Schwarz, Didier Lardinois, Grzegorz Terszowski, Spasenija Savic, Jens Schreiner, Sebastian Theurich, Kea Martin, Philipp Müller
Antibody–drug conjugates (ADC) are emerging as powerful treatment strategies with outstanding target-specificity and high therapeutic activity in patients with cancer. Brentuximab vedotin represents a first-in-class ADC directed against CD30+ malig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ced706dfc576c5b89a568e263ac21ec
https://doi.org/10.1158/2326-6066.c.6548374.v1
https://doi.org/10.1158/2326-6066.c.6548374.v1
Autor:
Jürgen Thiele, Hans Michael Kvasnicka, Attilio Orazi, Umberto Gianelli, Naseema Gangat, Alessandro M. Vannucchi, Tiziano Barbui, Daniel A. Arber, Ayalew Tefferi
Publikováno v:
American journal of hematologyREFERENCES. 98(1)
A group of international experts, including hematopathologists, oncologists, and geneticists were recently summoned (September 2021, Chicago, IL, USA) to update the 2016/17 World Health Organization classification system for hematopoietic tumors. Aft
Autor:
Umberto Gianelli, Jürgen Thiele, Attilio Orazi, Naseema Gangat, Alessandro M. Vannucchi, Ayalew Tefferi, Hans Michael Kvasnicka
Publikováno v:
Virchows Archiv : an international journal of pathologyReferences.
The recently published International Consensus Classification (ICC) of myeloid neoplasms summarized the results of an in-depth effort by pathologists, oncologists, and geneticists aimed to update the 2017 World Health Organization classification syst
Autor:
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans-Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso-Ramos, Jorge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S. Hobbs, Ronald Hoffman, Elias J. Jabbour, Jean-Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L.-C. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte Niemeyer, Olatoyosi M. Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P. Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A. Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi
Publikováno v:
Blood, 140(11), 1200-1228. American Society of Hematology
The classification of myeloid neoplasms and acute leukemias was last updated in 2016 within a collaboration between the World Health Organization (WHO), the Society for Hematopathology, and the European Association for Haematopathology. This collabor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f429b131a6a30560a6b776c66041ba
https://hdl.handle.net/2434/958017
https://hdl.handle.net/2434/958017